skip to main content

Options for Metastatic Spine Tumors Increase

Every kind of cancer can spread to the spine, yet two physician-scientists who treat these patients describe a lack of guidance for effectively providing care and minimizing pain.

Jagsi discusses advances in radiation therapy with U.S. News

In an article in U.S. News and World Report, Reshma Jagsi, M.D., D.Phil., describes recent advances in radiation therapy to treat breast cancer.

National Conferences

Every year, University of Michigan Rogel Cancer Center members, faculty, care providers, researchers and trainees have the opportunity to attend national and regional conferences. Here is a list of the most prominent:

Conference websites:

Clinical Seminars and Lectures

The following events are organized by and/or intended for those providing care to University of Michigan Rogel Cancer Center patients. These are not open to the general public.

View other calendars Patient and Family Events    |     Rogel Cancer Center Member Events    |    

Public and Community Outreach Events

The following calendar displays events that are sponsored or organized by the University of Michigan Rogel Cancer Center. All are open to the public -- but some may require registration.

If there are no events displayed on the calendar below, advance to the next month by clicking on the blue box with the arrow/triangle pointing to the right.

Cancer Center Patient and Family Calendar

Patient and family events are sponsored or organized by the Rogel Cancer Center and are free to our patients and their families, but may require registration. If you are not a patient, the Community Outreach / Public Events calendar will have items that may be of interest to you.

Other calendars:

Cancer Center All Events Calendar

The following events are sponsored by the University of Michigan Rogel Cancer Center and are intended for cancer center employees, faculty, trainees, researchers, members, patients and/or interested public.

View fewer options:

Wall Street Journal: Chemotherapy 'falls out of favor'

The Wall Street Journal looks at efforts to improve how oncologists determine which patients need chemotherapy. What once was a crucial part of cancer treatment might now be best avoided for some patients at low risk. The article cites research from U-M Rogel Cancer Center member Steven Katz, M.D., MPH.

U-M discovery helps build a better target for anticancer drug discovery

Cancerous cells are known activate an enzyme called telomerase, causing the cells to divide ceaselessly, a hallmark of cancer. Now, University of Michigan researchers have identified a region on a protein called TPP1 that binds this enzyme, which could provide a target for anticancer drugs.

1 in 7 lung surgery patients at risk for opioid dependence

Researchers found that 1 in 7 patients undergoing lung cancer surgery became new persistent opioid users after surgery, establishing opioid dependence as a postoperative complication that is as common as others, including atrial fibrillation.

Pages